Lyclear Dermal Cream

Quick links

Choose a section

Quick links to important sections

Advertisements

Lyclear Dermal Cream

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Lyclear Dermal Cream

What is Lyclear Dermal Cream? - Overview

Property Description
Active ingredient Permethrin
Form Dermal Cream (Topical)
Pharmacological class Ectoparasiticide
General Purpose Elimination of external parasites
Origin Synthetic pyrethroid

What Type of Medicine Is Lyclear Dermal Cream?

Lyclear Dermal Cream is a pharmaceutical preparation classified as an ectoparasiticide medicinal product intended for topical use. This classification signifies its specific purpose: to eliminate parasites that infest the external surfaces of the human body. The medicine is formulated as a Dermal Cream, meaning it utilizes a stable oil-in-water emulsion vehicle to facilitate the uniform and sustained application of the active agent directly onto the skin. The formulation is clinically recognized for its reliable performance in therapeutic scenarios requiring the elimination of mites and lice.


Composition and Origin: Is Permethrin Synthetic or Natural?

The single active ingredient in Lyclear Dermal Cream is Permethrin, which is chemically defined as a synthetic pyrethroid. Permethrin is not a purely natural compound; it is a laboratory-engineered substance derived from the structure of natural pyrethrins, which are found in the flowers of the Chrysanthemum family. The synthesis of this compound was crucial for its development as a stable therapeutic agent. Lyclear Dermal Cream is often available over-the-counter (OTC) in various jurisdictions, positioning it as an accessible, non-prescription option for patients requiring parasitic treatment.


What Is the General Purpose of This Ectoparasiticide?

The general purpose of this ectoparasiticide is the neutralization and elimination of parasitic organisms. The core function of the Permethrin within the cream is its potent, targeted neurotoxic action on the parasites. This action disrupts the pests' nervous systems, leading directly to rapid and irreversible paralysis. By inducing paralysis and subsequent death, the formulation serves as an efficient and standardized method for controlling and resolving ectoparasitic challenges in human patients.

Advertisements

What side effects are possible with Lyclear Dermal Cream?

Possible side effects and safety information

Official regulatory documentation classifies the potential adverse effects of Lyclear Dermal Cream (Permethrin 5%) primarily according to their frequency and the system they affect.

Frequency-Classified Adverse Reactions

The majority of documented effects relate to the site of application and are often transient (short-lived). These are grouped as follows:

  • Common (may affect up to 1 in 10 people): Reactions concerning the Skin and Subcutaneous Tissue Disorders, including a burning sensation, stinging, erythema (redness), rash, and pruritus (itching). Nervous System Disorders are also represented by paresthesia (tingling sensation).
  • Uncommon (may affect up to 1 in 100 people): Documented effects include headache, somnolence (drowsiness), or agitation.

Special Safety Considerations and Restrictions

Official safety documents note that the most significant safety restriction is a known hypersensitivity to permethrin, other pyrethrins, or any non-active ingredients in the cream, which serves as a contraindication. Though rare, severe generalized allergic responses, such as angioedema, are considered serious adverse reactions and are documented with a Not known frequency from post-marketing reports.

Regarding application patterns, some local skin reactions are expected to be transient. Furthermore, the temporary worsening or persistence of pruritus for up to four weeks following treatment is frequently noted in regulatory labels as an expected outcome related to the underlying condition itself, not necessarily an adverse effect of the medicine. The medicine is generally established for use in infants from 2 months of age and older, but is strictly limited to external use only.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents define the overdose profile of Permethrin 5% Dermal Cream based on the route of excessive exposure. Accidental ingestion may lead to systemic signs, including nausea, vomiting, dizziness, and headache. The most critical documented systemic effect is the potential for convulsions. When the cream is applied to the skin significantly in excess of the prescribed amount, the documented manifestation is typically limited to localised adverse reactions or more severe skin reactions.

Immediate Medical Intervention

Regulatory agencies mandate that individuals seek immediate medical aid from a medical professional or hospital Accident and Emergency Department in the event of any accidental ingestion, particularly when the contents of the tube are swallowed by a child. Immediate help is also required if severe hypersensitivity signs, such as swelling of the face, breathing difficulties, or loss of consciousness, are observed. For cases of ingestion, treatment procedures may include the consideration of gastric lavage if consultation is initiated within the defined window of two hours. If excessive cream is applied topically, the official instruction is to wash the affected area off with soap and warm water; the treatment for any resulting hypersensitivity reaction is documented as symptomatic.

Advertisements

Therapeutic Uses of Lyclear Dermal Cream

The core therapeutic purpose of Lyclear Dermal Cream (Permethrin 5% cream) is commonly used in situations involving symptoms related to inflammatory or irritative states. It is relevant in conditions presenting with significant symptomatic burden, such as scabies.

Addressing Ectoparasitic and Itchy Skin Conditions

This ectoparasiticide may assist in the management of the scabies mite (Sarcoptes scabiei) and is also relevant for managing certain louse infestations, such as crab lice (pediculosis pubis). The cream is applied in addressing symptom clusters that may become intense or disruptive, specifically pruritus (severe itching) and the associated irritative states. Its use is relevant in clinical settings marked by increased discomfort or tension, and it is commonly used when short-term symptomatic assistance is needed for the parasitic presence. This is particularly relevant in situations involving contagious episodes among family members and close contacts.

“The treatment is commonly applied in scenarios where symptoms escalate temporarily, assisting in the management of symptoms that create noticeable physiological strain.”

By addressing the parasitic presence, the treatment generally provides supportive relief from distressing symptoms that interfere with daily functioning, which contributes to easing the overall symptom load and improving day-to-day comfort during symptomatic periods.


Quick Fact: Relief for Intense Pruritus and Contagious Infestations

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Lyclear Dermal Cream?

The use of Lyclear Dermal Cream (Permethrin 5% cream) is strictly defined by official regulatory criteria, focusing on patient age and known sensitivities to the active ingredient.


Populations Excluded from Use

Use is contraindicated for patients with a known hypersensitivity or allergy to permethrin, to any excipient component of the cream, or to any compound belonging to the pyrethroid or pyrethrin chemical class. Additionally, the cream must not be used in infants under two months of age, as safety and effectiveness in this specific population have not been established by regulatory agencies.


Approved and Conditional Use

Population Group Regulatory Status
Standard Use Approved for adults, adolescents, and children two years of age and older, including geriatric patients.
Infants (2–23 months) Use is restricted and requires close medical supervision due to limited clinical experience in this young subgroup.
Pregnancy Use is conditional (classified as Category B) and should only occur if clearly needed.
Lactation Consideration must be given to temporarily discontinuing nursing or withholding the drug while breastfeeding.

Furthermore, application is restricted; the cream must be strictly avoided on broken skin, severe inflammatory lesions, or near mucous membranes, including the eyes, nose, and mouth.

Advertisements

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Lyclear Dermal Cream


Interaction scope

Category Official Regulatory Finding
Medicinal product categories with documented interactions Topical Corticosteroids (Steroids); Latex Products (as an excipient interaction).
Specific interacting medicines (if explicitly listed) None explicitly listed in regulatory interaction sections as systemic interactants; only the class Topical Corticosteroids is noted for administration restriction.
Mechanistic basis of interactions (only if stated in label) None known for systemic drug-drug interactions. The restriction with topical corticosteroids is based on the official statement that they may interfere with the body's natural defensive response to the parasitic infestation.
Timing-based interaction rules (if applicable) Treatment with topical corticosteroids for associated skin conditions should be withheld prior to treatment with Permethrin 5% w/w Cream.
Population-specific interaction notes (if applicable) None documented. Official labeling does not specify altered interaction severity or nature in specific populations.
Interaction-related restrictions Co-administration of the cream must be considered with latex barrier contraceptives (e.g., condoms, diaphragms) due to the presence of excipients that reduce their efficiency and reliability.

Interaction classifications (high-level)

Classification Official Regulatory Finding
Interaction severity classification (as defined in official documents) Not classified as "Contraindicated" for systemic co-administration. Classified as an Administration Restriction / Caution for Concurrent Use.
Regulatory basis (EMA / FDA / etc.) Information derived from SmPC and FDA labeling documents.
Interaction-context constraints (as defined in official documents) Non-Systemic / Excipient-Related Interactions dominate the documented interaction profile.

Resulting interaction structure

Official interaction statements:

  • No known systemic drug interactions are documented for Lyclear Dermal Cream.
  • Topical Corticosteroids should be withheld prior to treatment with the cream.
  • Cream excipients reduce the efficiency and reliability of concurrent latex barrier contraceptives.
  • No specific interactions with food, alcohol, or herbal products are documented in the official regulatory labels.

Connection to the overall interaction profile (2–4 sentences):

The regulatory documentation defines this product's interaction structure as primarily non-systemic, characterized by the official statement of no known systemic drug interactions with other medicines. The profile is limited to a procedural restriction regarding the timing of co-administered topical corticosteroids and a documented material compatibility constraint concerning the cream's excipients and latex products. This structure is consistent across government regulatory sources, summarizing the official constraints on concurrent administration.

Advertisements

Mechanism of Action

Targeting the Arthropod's Voltage-Gated Sodium Channels

The primary mechanism of Permethrin involves acting as a Sodium Channel Modulator within the nerve membranes of the target ectoparasites. By binding specifically to the Voltage-Gated Sodium Channels (VGSCs), the molecule prevents them from closing properly after they have opened. This action initiates a persistent influx of sodium ions into the nerve cell, which is the foundational molecular step of the drug's mechanism.


The Cascade of Neuro-Excitation leading to Generalized Paralysis

This sustained flow of sodium ions forces the nerve axon into a state of hyperexcitation, causing a relentless, high-frequency discharge of electrical signals—a train of impulses—throughout the parasite's nervous system. This destabilization of neurological control quickly translates into widespread, uncontrollable muscle spasms, progressing to generalized paralysis. The resulting physiological destabilization of the parasite's vital systems is a physiological consequence of the neurotoxicity.


Biological Constraints on Mechanism Efficacy (Resistance)

The effectiveness of this neurotoxic mechanism can be limited by the parasite's counter-mechanisms, such as Target Site Resistance (genetic changes that reduce Permethrin's binding affinity to the VGSC) and Metabolic Resistance (increased activity of detoxifying enzymes like Cytochrome P450s). In these cases, the drug cannot effectively engage the neuro-excitation cascade.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Lyclear Dermal Cream (Permethrin 5% w/w) is a formulation approved exclusively for cutaneous use. The medicine is applied topically to the skin and is strictly prohibited from being swallowed. The standard treatment course is structured around a single application to the whole body.


Dosing and Frequency

For adults and adolescents over 12 years, the labeled dose is up to 30 grams of the 5% cream, which generally corresponds to one full tube. The official dosing schedule for children is stratified by age: those aged 6 to 12 years are given up to 15 grams, and children aged 2 months to 5 years receive up to 7.5 grams. While a single application is typically sufficient, re-treatment is only permitted after an interval of 7 to 14 days from the initial course if required.


Procedural Requirements

The protocol requires the cream to be applied to clean, dry, and cool skin, covering the entire body surface from the neck down to the soles of the feet. A critical component of the usage protocol is the prescribed contact time: the cream must remain on the skin for a duration of 8 to 14 hours before being completely washed off thoroughly in a bath or shower. If hands are washed during the treatment period, the cream must be immediately re-applied to the hands and wrists. For infants and older adults over 65, the application must be extended to include the scalp, face, and ears.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lyclear Dermal Cream (Permethrin 5%)

Evidence for Use in Scabies Infestation

Research has explored the use of Lyclear Dermal Cream for the treatment of scabies, a condition characterized by fluctuating or episodic manifestations. Research has primarily involved short-term Randomized Controlled Trials (RCTs), where the product was evaluated against a placebo or other approved scabies treatments. These studies examined outcomes related to patient-reported discomfort and microscopic confirmation of the absence of the scabies mite.

Clinical studies reported patterns related to the proportion of people achieving absence of the mite in groups assigned to the product, a placebo, or an alternative treatment. However, long-term outcomes regarding the durability of the observed pattern and detailed recurrence rates beyond three months are not fully established. Additionally, evidence quality varies across studies due to differing diagnostic criteria for cure.


Evidence for Use in Head Lice Infestation

Research has explored the use of the active ingredient present in Lyclear Dermal Cream against head lice, a condition associated with episodic manifestations. Studies explored various formulations containing the active ingredient, often at a 1% concentration or as a cream rinse, and other approved treatments. These trials examined visual outcomes related to the absence of live lice and viable eggs (nits).

Evidence is limited regarding the 5% dermal cream specifically for head lice, as much of the core research is based on the 1% concentration or a cream rinse formulation. Follow-up durations were often limited in these studies, meaning that the research provides limited insight into long-term changes or the rate of re-infestation after the study period concludes.


Research in Specific Patient Groups

Studies have been conducted on populations including children, often down to two months of age in some study designs, examining outcomes related to symptom patterns. However, data for certain groups remain insufficient. Specifically, comparative evidence is lacking or still emerging for key populations such as pregnant or breastfeeding women. Furthermore, subgroup findings are uncertain or limited for older adults with complex health histories.

Findings describe group patterns, not personal outcomes, and the research does not determine whether an individual will respond similarly.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Lyclear Dermal Cream (FAQ)


Q: Does Lyclear Dermal Cream treat conditions other than scabies?

A: Regulatory documents state that Lyclear Dermal Cream is indicated for the treatment of both scabies and crab lice (pubic lice) infestations. Its active ingredient is classified as an ectoparasiticide, designed to target and eliminate external parasites.


Q: What is the difference between Lyclear Dermal Cream and oral treatments for scabies?

A: Lyclear Dermal Cream is a topical treatment, meaning it is applied externally to the skin to exert its effect locally. In contrast, other approved treatments for scabies, such as ivermectin, are administered orally (by mouth). Regulatory guidance references both types of treatment as therapeutic options.


Q: How quickly does Lyclear Dermal Cream start working after application?

A: The active ingredient, permethrin, is a neurotoxin that begins acting on the parasite's nervous system shortly after exposure. This neurotoxic action causes hyperexcitability and then paralysis in the parasite, which is the foundational step toward elimination.


Q: Why does itching sometimes get worse immediately following treatment?

A: Official product information notes that skin irritation, rash, or pruritus (itching) may temporarily worsen shortly after treatment. This temporary worsening is not generally described as a sign of treatment failure. It is often considered part of the natural healing process of scabies or potentially an allergic reaction to the dead mites present in the skin.


Q: What signs indicate that the treatment may need to be repeated?

A: Regulatory documents indicate that a single application is often considered sufficient for many people. Re-treatment is typically only permitted if there is proof of demonstrable living mites found on the skin, usually 14 days or more after the initial application. Persistent itching alone is rarely used as a sign of necessary re-treatment.


Q: Are there any specific health conditions, like asthma or eczema, that require extra caution before using the cream?

A: Official warnings state that the cream may worsen symptoms of existing asthma or eczema. For people with known allergies to certain plants, specifically chrysanthemums or other compositae, official warnings state that use should only proceed after consulting a doctor.


Q: Can the cream be used while taking other skin products, such as moisturisers or lotions?

A: Regulatory documents state there are no known systemic interactions with other medicines. However, official information does address an administration restriction concerning Topical Corticosteroids, which should be withheld. General moisturisers and lotions are not specifically addressed as interactants.


Q: What should be done if severe skin irritation occurs after applying the cream?

A: If a rash, irritation, or other reaction persists or becomes severe, or if serious symptoms such as trouble breathing occur, official guidance recommends that individuals should contact a healthcare professional or pharmacist.


Q: Can Lyclear Dermal Cream worsen symptoms of existing eczema or asthma?

A: Regulatory warnings indicate that the cream has the potential to worsen symptoms of pre-existing asthma or eczema in some individuals. This is noted in official product information as a point of caution.


Q: Is Lyclear Dermal Cream effective against the eggs of the mites or lice?

A: The active ingredient, permethrin, exerts its primary action on the nervous system of live mites and lice. For the treatment of head lice, the 1% concentration is sometimes noted as not being highly effective against unhatched eggs, which is why a second application is often employed to eliminate newly hatched parasites.


Q: Is it safe to apply the cream to the genital area or other sensitive skin folds?

A: The application protocol generally describes applying the cream to the whole body, which is understood to include areas such as the genitals, inner thighs, and skin folds. However, the cream must be strictly kept away from mucous membranes, such as the eyes, nose, and mouth.


Q: Are there specific body areas that should be treated for crab lice compared to scabies?

A: Yes, the areas targeted are different. For scabies, the application covers the whole body from the neck down. For crab lice, application focuses on the pubic region, peri-anal area, inner thighs, and any hair that grows up toward the chest or stomach.


Q: Is it necessary to treat all close contacts, even if they have no symptoms?

A: Official public health guidance often advises that simultaneous treatment of close contacts (such as family members and sexual partners) is a preventative measure. This is suggested to help interrupt the cycle of infestation, even if contacts do not show symptoms yet.


Q: How long after treatment is a person typically considered no longer contagious?

A: Clinical guidance suggests that a person is generally considered no longer contagious 24 hours following the required contact period and removal of the cream. This time frame is referenced after the required 8 to 14 hours that the cream must remain on the skin.


Q: Why is it recommended to apply the cream to cool, dry skin?

A: Official documentation describes the procedural requirement that the cream is to be applied to skin that is clean, dry, and cool. Some product labels advise against using the cream immediately after a hot bath or shower, as heat may potentially affect the drug's consistency or increase skin absorption.


Q: How do the concentrations of permethrin absorbed through the skin compare to concentrations in breast milk?

A: The average amount of permethrin absorbed through the skin is documented as very small, less than 2% of the applied dose. It is not known whether this minimal amount of the drug is excreted into human milk, which is the basis for the caution regarding its use while breastfeeding.


Q: Are there any special considerations for people who have sensitive skin when using the cream?

A: The cream contains non-active ingredients, or excipients, such as butylhydroxytoluene that may cause local skin reactions, like contact dermatitis, in some individuals. This is a point of consideration documented for people with sensitive skin.


Q: What is the official safety classification of permethrin cream during human exposure?

A: In the US (FDA), permethrin 5% cream has been assigned a Pregnancy Category B classification. This classification indicates that while animal studies have not shown risk, there are not currently adequate and well-controlled studies in pregnant women.


Q: How long after the first application can I expect the itching to stop completely?

A: Official information indicates that it is common for the itching to persist for up to four weeks after the treatment, even if successful. If irritation or itching persists past this four-week period, official guidance indicates that consulting a healthcare professional may be necessary.


Q: Is a second application always necessary, or is one application generally sufficient?

A: Official regulatory documents indicate that a single application is often considered sufficient for the majority of people. A second application is only permitted if there is clinical or microscopic evidence of live mites 7 to 14 days following the initial course.


Q: Do you need a prescription to get Lyclear Dermal Cream in certain countries?

A: In many jurisdictions, the cream is classified as an Over-The-Counter (OTC) product and is available without a prescription. However, regulatory status and classification can vary depending on the specific country or region.


Q: Can the cream be accidentally licked off by infants, and how is this prevented?

A: Since infants require application to the face and scalp, the areas of skin immediately around the mouth should be spared during application. Furthermore, official instructions note that the use of gloves on infants’ hands can help prevent the cream from being licked off.


Q: Is it safe to use Lyclear Dermal Cream if I am allergic to chrysanthemums or ragweed?

A: Permethrin is a synthetic pyrethroid derived from the structure of natural pyrethrins, which are found in the Chrysanthemum family. For individuals with known allergies to chrysanthemums or other compositae, official warnings indicate that use should only proceed after consultation with a doctor.

Advertisements

How should Lyclear Dermal Cream be stored and disposed of?

Official Storage and Disposal Requirements

Storage and disposal requirements for Lyclear Dermal Cream (Permethrin 5% w/w) are defined in regulatory documents to ensure product stability and environmental safety.

Requirement Area Official Instructions
Temperature & Stability Do not freeze the cream. Must be kept in the original container. Storage typically requires no special conditions (or below 25 C/30 C per license).
Child Safety Must be kept out of the sight and reach of children.
Handling & Fire Hazard Fabric (clothing, bedding, etc.) contaminated with the cream is a serious fire hazard. Keep away from fire. Carers should consider wearing gloves during application.
Disposal Dispose of unused or expired product according to local requirements (e.g., pharmacy take-back programs). Permethrin is harmful to aquatic life; avoid contamination of aquaria and terraria.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lyclear Dermal Cream found in:

A-Z Index: